Heru explained that the housing subsidy for employees at the Ministry of Home Affairs aims to improve the welfare of workers ...

Replimune Group's RP1 oncolytic virus therapy faced an FDA rejection, raising concerns about the platform's viability in ...

Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic ...

George Tidmarsh takes over temporarily at CBER following Vinay Prasad’s abrupt departure; Replimmune trial leaders protest ...

President Prabowo Subianto instructed Health Minister Budi Gunadi Sadikin to increase the number of dentists at public health ...

PT Teladan Prima Agro Tbk (TLDN) delivered stellar results in the first half of 2025, booking a net profit of Rp561.28 billion ...

In an open letter, 22 experts who designed and ran Replimmune’s Phase III IGNYTE trial answered the FDA’s issues, as outlined ...

PT Pradiksi Gunatama Tbk (PGUN), a palm oil company owned by Indonesian tycoon Andi Syamsuddin Arsyad (popularly known as ...

Hearing minnow Audeara has entered an alliance with Ear Science Institute Australia to develop an affordable bone conduction hearing device.

Shares of Replimune Group Inc. (NASDAQ:REPL) plunged 36% in premarket trading after a report revealed new details about the ...